TEVA icon

Teva Pharmaceuticals

772 hedge funds and large institutions have $29.6B invested in Teva Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 60 funds opening new positions, 254 increasing their positions, 309 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
772
Holders Change
-7
Holders Change %
-0.9%
% of All Funds
22.42%
Holding in Top 10
47
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-4.08%
% of All Funds
1.36%
New
60
Increased
254
Reduced
309
Closed
65
Calls
$1.34B
Puts
$589M
Net Calls
+$755M
Net Calls Change
-$241M
Name Holding Trade Value Shares
Change
Shares
Change %
NIMC
26
NWQ Investment Management Company
California
$249M -$20.5M -387,600 -8%
American Century Companies
27
American Century Companies
Missouri
$236M +$7.21M +134,217 +3%
Acadian Asset Management
28
Acadian Asset Management
Massachusetts
$220M +$67.4M +1,254,122 +44%
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$212M +$7.01M +130,325 +3%
FTCM
30
Fir Tree Capital Management
New York
$206M +$64M +1,191,300 +45%
ClearBridge Investments
31
ClearBridge Investments
New York
$189M -$1.43M -26,531 -0.7%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$159M +$27.4M +510,403 +21%
U
33
UBS
Switzerland
$157M +$33.4M +621,771 +27%
Brown Advisory
34
Brown Advisory
Maryland
$154M +$15.5M +289,152 +11%
Nordea Investment Management
35
Nordea Investment Management
Sweden
$152M +$55M +1,023,299 +56%
BG
36
BlackRock Group
United Kingdom
$149M +$31.7M +590,214 +27%
SCM
37
Scopia Capital Management
New York
$144M +$143M +2,669,446 +33,243%
JHIU
38
Janus Henderson Investors US
Colorado
$143M +$19M +353,667 +15%
BIM
39
BlackRock Investment Management
Delaware
$142M +$59.9M +1,114,323 +73%
Neuberger Berman Group
40
Neuberger Berman Group
New York
$141M -$4.13M -76,852 -3%
Wells Fargo
41
Wells Fargo
California
$124M +$3.87M +71,928 +3%
TGI
42
Tradewinds Global Investors
California
$123M -$3.38M -62,894 -3%
Deutsche Bank
43
Deutsche Bank
Germany
$122M -$33.5M -622,916 -21%
PHS
44
PFM Health Sciences
California
$116M -$72.7M -1,352,381 -38%
Jennison Associates
45
Jennison Associates
New York
$114M -$97.2M -1,807,533 -46%
Janus Henderson Group
46
Janus Henderson Group
United Kingdom
$113M +$30.3M +563,830 +37%
Arrowstreet Capital
47
Arrowstreet Capital
Massachusetts
$111M +$108M +2,005,706 +3,011%
CS
48
Credit Suisse
Switzerland
$110M +$23.7M +440,053 +27%
NTC
49
North Tide Capital
Massachusetts
$108M -$53.8M -1,000,000 -33%
Morgan Stanley
50
Morgan Stanley
New York
$106M +$11M +204,458 +12%